KBC Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$201K Hold
2,411
﹤0.01% 972
2025
Q4
$221K Hold
2,411
﹤0.01% 885
2025
Q3
$228K Hold
2,411
﹤0.01% 854
2025
Q2
$253K Sell
2,411
-1,341
-36% -$127K ﹤0.01% 789
2025
Q1
$332K Sell
3,752
-108
-3% -$11.1K ﹤0.01% 813
2024
Q4
$370K Buy
3,860
+1,397
+57% +$130K ﹤0.01% 873
2024
Q3
$202K Buy
2,463
+341
+16% +$26.3K ﹤0.01% 928
2024
Q2
$183K Buy
2,122
+249
+13% +$20.1K ﹤0.01% 888
2024
Q1
$153K Buy
1,873
+292
+18% +$22.8K ﹤0.01% 938
2023
Q4
$105K Hold
1,581
﹤0.01% 1046
2023
Q3
$115K Buy
+1,581
New +$107K ﹤0.01% 957

Other funds holding HQY

KBC Group's HQY Position: Q1 2026 in Review

KBC Group held its HealthEquity (HQY) position steady in Q1 2026 at 2,411 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

KBC Group first reported a position in HQY in Q3 2023 and has held it in 11 quarters since. The position peaked at $370K in Q4 2024. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • KBC Group held 2,411 shares of HealthEquity worth $201K as of Q1 2026.
  • KBC Group left its HealthEquity share count unchanged in Q1 2026.
  • HealthEquity made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #972 holding.
  • KBC Group first reported a position in HealthEquity in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's HealthEquity position peaked at $370K in Q4 2024.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.